Mirati Therapeutics, Inc. (NASDAQ:MRTX) Q2 2023 Earnings Conference Call August 8, 2023 4:30 PM ET
Company Participants
Ryan Asay - Vice President-Corporate Affairs
Chuck Baum - President, Founder & Interim Chief Executive Officer
Alan Sandler - Chief Medical Officer
Jamie Christensen - Chief Scientific Officer
Ben Hickey - Chief Commercial Officer
Laurie Stelzer - Chief Financial Officer
Conference Call Participants
Michael Schmidt - Guggenheim
Tyler Van Buren - TD Cowen
Jay Olson - Oppenheimer
Gena Wang - Barclays
Jonathan Miller - Evercore
Jason Gerberry - Bank of America
Ben Burnett - Stifel
Mike Ulz - Morgan Stanley
Yigal Nochomovitz - Citigroup
Evan Seigerman - BMO
Operator
Good afternoon, and welcome to the Mirati Therapeutics Second Quarter 2023 Earnings Call. My name is Justin, and I will be the operator for today's call. All lines have been placed on mute to prevent any background noise. After the conclusion of the speakers' prepared remarks, there will be the question-and-answer session. [Operator Instructions]
It is my pleasure to introduce Ryan Asay, Vice President of Corporate Affairs at Mirati. Ryan, you may begin the call.
Ryan Asay
Thank you, Justin, and welcome everyone to this afternoon's call. Joining me on the call today are Dr. Chuck Baum, our President and Founder; Dr. Alan Sandler, our Chief Medical Officer; Dr. Jamie Christensen, our Chief Scientific Officer; Ben Hickey, our Chief Commercial Officer; and Laurie Stelzer our Chief Financial Officer.
I'd like to inform you that certain statements we make during this call will be forward looking. Because such statements deal with future events and are subject to many risks and uncertainties actual results may differ materially from those in the forward-looking statements. For a full discussion of these risks and uncertainties, please review our annual report on Form 10-K and our quarterly reports on Form 10-Q that are filed with the US Securities and Exchange Commission.
This afternoon, we released financial results for the quarter ended June 30, 2023 and recent corporate updates. This press release and accompanying second quarter earnings slide presentation are available on the Investors section of our website at mirati.com. Additionally, this afternoon we also announced the launch of a public offering. This presentation shall not constitute an offer to sell or the solicitation of an offer to buy our securities. The securities described are being offered pursuant to a shelf registration, statements filed by us with the SEC that became automatically effective upon filing.